Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Expression of Osteopontin in Non-small Cell Lung Cancer and Correlative Relation with Microvascular Density

  • Yu, Ting-Ting (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University) ;
  • Han, Zhi-Gang (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University) ;
  • Shan, Li (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University) ;
  • Tao, Jie (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University) ;
  • Zhang, Tao (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University) ;
  • Yuan, Shuai-Fei (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University) ;
  • Shen, Hong-Li (Department of Chemotherapy, Tumor Hospital Affiliated to Xinjiang Medical University)
  • Published : 2014.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background and Objective: Lung cancer is one of the malignant diseases which most seriously threat humansurvival and development. This study aimed to assess osteopontin (OPN) expression in non-small cell lung cancer (NSCLC) and any relationship with clinicopathological features. Methods: Immunohistochemistry was used to determine OPN expression and microvascular density (MVD) in 120 cases of NSCLC also undergoing clinical assessment. Results: Moderately positive expression of OPN was found in 34.6% (41/120) and strong expression in 47.5% (57/120) of the NSCLCs; OPN expression in carcinomas was higher than in pericarcinoma tissues (P<0.05). While no obvious association was observed with NSCLC patient age, gender, maximum diameter of the tumor and pathological type, OPN expression was more commonly detected in poorly differentiated carcinoma tissue and lymph node metastasis as well as at advanced clinical stage (P<0.05); OPN expression in cancer tissue was positively correlated with MVD (r = 0.839, P = 0.000). Conclusion: OPN plays an important role in promoting tumor angiogenesis and progress of NSCLCs and has the possibility to become the new target for therapy.

Keywords

References

  1. Elli M, Dagdemir A, Bozkurt C, et al (2012). Serum osteopontin and CD44 levels in lymphoreticular malignancies in children. Bratisl Lek Listy, 113, 534-8.
  2. Hartung F, Weber GF (2013). RNA blood levels of osteopontin splice variants are cancer markers. Springer Plus, 2, 110. https://doi.org/10.1186/2193-1801-2-110
  3. Huan JL, Xing L, Qin XJ, et al (2012). Expression and clinical significance of osteopontin in calcified breast tissue. Asian Pac J Cancer Prev, 13, 5219-23. https://doi.org/10.7314/APJCP.2012.13.10.5219
  4. Huang J, Pan C, Hu H, Zheng S, Ding L (2012). Osteopontin enhanced hepatic metastasis of colorectal cancer cells. PLoS One, 7, e47901. https://doi.org/10.1371/journal.pone.0047901
  5. Ito S, Miyahara R, Takahashi R, et al (2009). Stromal aminopeptidase N expression: correlation with angiogenesis in non-small-cell lung cancer. Gen Thorac Cardiovasc Surg, 57, 591-8. https://doi.org/10.1007/s11748-009-0445-x
  6. Lund SA, Wilson CL, Raines EW, et al (2013). Osteopontin mediates macrophage chemotaxis via ${\alpha}$4 and ${\alpha}$9 integrins and survival via the ${\alpha}$4 integrin. J Cell Biochem, 114, 1194-202. https://doi.org/10.1002/jcb.24462
  7. Luo X, Ruhland MK, Pazolli E, Lind AC, Stewart SA (2011). Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Mol Cancer Res, 9, 1018-29. https://doi.org/10.1158/1541-7786.MCR-10-0472
  8. Maeda R, Ishii G, Ito M, et al (2012). Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes. J Thorac Oncol, 7, 503-11. https://doi.org/10.1097/JTO.0b013e318241780e
  9. Matusan-Ilijas K, Damante G, Fabbro D, et al (2011). Osteopontin expression correlates with nuclear factor-${\kappa}$B activation and apoptosis down regulation in clear cell renal cell carcinoma. Pathol Res Pract, 207, 104-10. https://doi.org/10.1016/j.prp.2010.11.004
  10. Qin LF, Wang WC, Fang H, et al (2013). Expression of NF-${\kappa}$B and osteopontin of synovial fluid of patients with knee osteoarthritis. Asian Pac J Trop Med, 6, 379-382. https://doi.org/10.1016/S1995-7645(13)60042-5
  11. Qiu ZB, Xu H, Duan C, Xin C (2012). Osteopontin is required for angiotensin II-induced migration of vascular smooth muscle cells. Pharmazie, 67, 553-8.
  12. Rao G, Wang H, Li B, et al (2013). Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clin Cancer Res, 19, 785-97. https://doi.org/10.1158/1078-0432.CCR-12-2788
  13. Samitas K, Zervas E, Xanthou G, Vily P, Gaga M (2013). Osteopontin is increased in the bronchoalveolar lavage fluid and bronchial tissue of smoking asthmatics. Cytokine, 61, 713-5. https://doi.org/10.1016/j.cyto.2012.12.028
  14. Sun BS, You J, Li Y, Zhang ZF, Wang CL (2013).Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis. Chin Med J (Engl), 126, 1683-8.
  15. Tsai WC, Tsai WC, Lee HS, et al (2012). Association between Osteopontin and EGFR Expression with Clinicopathological Parameters in Hepatocellular Carcinoma. Chin J Physiol, 55, 412-20. https://doi.org/10.4077/CJP.2012.BAA082

Cited by

  1. Serum anti-osteopontin autoantibody as a novel diagnostic and prognostic biomarker in patients with hepatocellular carcinoma vol.32, pp.4, 2014, https://doi.org/10.3892/or.2014.3367
  2. The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis vol.45, pp.5, 2014, https://doi.org/10.1007/s10735-014-9574-3
  3. Overexpression of osteopontin promotes resistance to cisplatin treatment in HCC vol.34, pp.6, 2015, https://doi.org/10.3892/or.2015.4306
  4. Correlation between lung neoplasm and serum level of osteopontin: A meta-analysis vol.4, pp.5, 2016, https://doi.org/10.3892/br.2016.619
  5. Prognostic value of osteopontin in patients with hepatocellular carcinoma vol.97, pp.43, 2018, https://doi.org/10.1097/MD.0000000000012954